CTO at Aura Biosciences

October 2, 2023
CTO at Aura Biosciences

Aura Biosciences Inc., a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the appointment of Mark Plavsic, Ph.D., as Chief Technology Officer.